Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cheyne Kurokawa

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Virus Research|January 27, 2019
A key anti-viral protein, RSAD2/VIPERIN, restricts the release of measles virus from infected cellsCheyne Kurokawa, Ianko D Iankov, Evanthia Galanis
Nature Reviews. Microbiology|July 12, 2020
Interactions between Borrelia burgdorferi and ticksCheyne Kurokawa, Geoffrey E Lynn, Joao H F Pedra, et al.
Parasite Immunology|November 13, 2020
Acquired tick resistance: The trail is hotSukanya Narasimhan, Cheyne Kurokawa, Melody DeBlasio, et al.
Molecular Therapy Oncolytics|November 4, 2020
Live Attenuated Measles Virus Vaccine Expressing <i>Helicobacter</i> <i>pylori</i> Heat Shock Protein AIanko D Iankov, Cheyne Kurokawa, Kimberly Viker, et al.
Ticks and Tick-Borne Diseases|August 13, 2022
Immunization of guinea pigs with cement extract induces resistance against Ixodes scapularis ticksGeoffrey E Lynn, Jiří Černý, Cheyne Kurokawa, et al.
Neuro-Oncology|September 25, 2016
Immunovirotherapy with measles virus strains in combination with anti-PD-1 antibody blockade enhances antitumor activity in glioblastoma treatmentJayson Hardcastle, Lisa Mills, Courtney S Malo, et al.
The Journal of Clinical Investigation|July 1, 2021
Immunostimulatory bacterial antigen-armed oncolytic measles virotherapy significantly increases the potency of anti-PD1 checkpoint therapyEleni Panagioti, Cheyne Kurokawa, Kimberly Viker, et al.
Ticks and Tick-Borne Diseases|September 30, 2020
Repeat tick exposure elicits distinct immune responses in guinea pigs and miceCheyne Kurokawa, Sukanya Narasimhan, Aurobind Vidyarthi, et al.
Vaccine|December 4, 2021
Tick immunity using mRNA, DNA and protein-based Salp14 delivery strategiesJaqueline Matias, Cheyne Kurokawa, Andaleeb Sajid, et al.
Science Translational Medicine|November 17, 2021
mRNA vaccination induces tick resistance and prevents transmission of the Lyme disease agentAndaleeb Sajid, Jaqueline Matias, Gunjan Arora, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Virus Research|January 27, 2019
A key anti-viral protein, RSAD2/VIPERIN, restricts the release of measles virus from infected cellsCheyne Kurokawa, Ianko D Iankov, Evanthia Galanis
Nature Reviews. Microbiology|July 12, 2020
Interactions between Borrelia burgdorferi and ticksCheyne Kurokawa, Geoffrey E Lynn, Joao H F Pedra, et al.
Parasite Immunology|November 13, 2020
Acquired tick resistance: The trail is hotSukanya Narasimhan, Cheyne Kurokawa, Melody DeBlasio, et al.
Molecular Therapy Oncolytics|November 4, 2020
Live Attenuated Measles Virus Vaccine Expressing <i>Helicobacter</i> <i>pylori</i> Heat Shock Protein AIanko D Iankov, Cheyne Kurokawa, Kimberly Viker, et al.
Ticks and Tick-Borne Diseases|August 13, 2022
Immunization of guinea pigs with cement extract induces resistance against Ixodes scapularis ticksGeoffrey E Lynn, Jiří Černý, Cheyne Kurokawa, et al.
Neuro-Oncology|September 25, 2016
Immunovirotherapy with measles virus strains in combination with anti-PD-1 antibody blockade enhances antitumor activity in glioblastoma treatmentJayson Hardcastle, Lisa Mills, Courtney S Malo, et al.
The Journal of Clinical Investigation|July 1, 2021
Immunostimulatory bacterial antigen-armed oncolytic measles virotherapy significantly increases the potency of anti-PD1 checkpoint therapyEleni Panagioti, Cheyne Kurokawa, Kimberly Viker, et al.
Ticks and Tick-Borne Diseases|September 30, 2020
Repeat tick exposure elicits distinct immune responses in guinea pigs and miceCheyne Kurokawa, Sukanya Narasimhan, Aurobind Vidyarthi, et al.
Vaccine|December 4, 2021
Tick immunity using mRNA, DNA and protein-based Salp14 delivery strategiesJaqueline Matias, Cheyne Kurokawa, Andaleeb Sajid, et al.
Science Translational Medicine|November 17, 2021
mRNA vaccination induces tick resistance and prevents transmission of the Lyme disease agentAndaleeb Sajid, Jaqueline Matias, Gunjan Arora, et al.
Pageof 2